These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9372534)

  • 1. Amphetamine-induced withdrawal responding: effects of repeated drug administration.
    Caul WF; Stadler JR; Barrett RJ
    Psychopharmacology (Berl); 1997 Oct; 133(4):351-5. PubMed ID: 9372534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
    Stadler JR; Caul WF; Barrett RJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound responding following a single dose of drug using an amphetamine-vehicle-haloperidol drug discrimination.
    Caul WF; Barrett RJ; Huffman EM; Stadler JR
    Psychopharmacology (Berl); 1996 Dec; 128(3):274-9. PubMed ID: 8972547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated haloperidol administration on phencyclidine discrimination in rats.
    Wiley JL
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):699-711. PubMed ID: 8588067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedule-dependent effects of haloperidol and amphetamine: multiple-schedule task shows within-subject effects.
    Caul WF; Brindle NA
    Pharmacol Biochem Behav; 2001 Jan; 68(1):53-63. PubMed ID: 11274708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of training dose on amphetamine drug discrimination: dose-response functions and generalization to cocaine.
    Stadler JR; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 2001; 70(2-3):381-6. PubMed ID: 11701211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine partial agonist reverses amphetamine withdrawal in rats.
    Orsini C; Koob GF; Pulvirenti L
    Neuropsychopharmacology; 2001 Nov; 25(5):789-92. PubMed ID: 11682262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug.
    Pierre PJ; Vezina P
    Psychopharmacology (Berl); 1998 Jul; 138(2):159-66. PubMed ID: 9718285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
    Schwabe K; Koch M
    Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task.
    Barrett RJ; Caul WF; Smith R
    Pharmacol Biochem Behav; 2005 May; 81(1):1-8. PubMed ID: 15894057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebound cue state following a single dose of haloperidol.
    Caul WF; Jones JR; Schmidt TA; Murphy SM; Barrett RJ
    Life Sci; 1991; 49(17):PL119-24. PubMed ID: 1943434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of ondansetron and alpha-flupenthixol on responding for conditioned reward.
    Fletcher PJ; Higgins GA
    Psychopharmacology (Berl); 1997 Nov; 134(1):64-72. PubMed ID: 9399368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.
    Cheng RK; Liao RM
    Chin J Physiol; 2007 Apr; 50(2):77-88. PubMed ID: 17608145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D; Thisted RA; Nichols DE
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal.
    Barrett RJ; Caul WF; Smith RL
    Pharmacol Biochem Behav; 2004 Dec; 79(4):761-71. PubMed ID: 15582685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination.
    Barrett RJ; White DK; Caul WF
    Psychopharmacology (Berl); 1992; 109(1-2):63-7. PubMed ID: 1365673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
    Smith JK; Neill JC; Costall B
    Pharmacol Biochem Behav; 1997 Aug; 57(4):843-9. PubMed ID: 9259014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dopamine autoreceptor antagonist (-)-DS121 on the discriminative stimulus properties of d-amphetamine and cocaine.
    Clark D; Exner M; Furmidge LJ; Svensson K; Sonesson C
    Eur J Pharmacol; 1995 Feb; 275(1):67-74. PubMed ID: 7774664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.